Cargando…
Metabolomic and lipidomic approaches to identify biomarkers for bladder cancer and interstitial cystitis
The discovery, introduction and clinical use of prognostic and diagnostic biomarkers has significantly improved outcomes for patients with various illnesses, including bladder cancer (BC) and other bladder-related diseases, such as benign bladder dysfunction and interstitial cystitis (IC). Several s...
Autores principales: | Shahid, Muhammad, Yeon, Austin, Kim, Jayoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7646957/ https://www.ncbi.nlm.nih.gov/pubmed/33174036 http://dx.doi.org/10.3892/mmr.2020.11627 |
Ejemplares similares
-
Metabolomics Insights Into Pathophysiological Mechanisms of Interstitial Cystitis
por: Fiehn, Oliver, et al.
Publicado: (2014) -
'Omics' Approaches to Understanding Interstitial Cystitis/Painful Bladder Syndrome/Bladder Pain Syndrome
por: You, Sungyong, et al.
Publicado: (2012) -
Antiproliferative Factor Signaling and Interstitial Cystitis/Painful Bladder Syndrome
por: Kim, Jayoung, et al.
Publicado: (2011) -
Classification of the urinary metabolome using machine learning and potential applications to diagnosing interstitial cystitis
por: Tong, Feng, et al.
Publicado: (2020) -
Menthol, a unique urinary volatile compound, is associated with chronic inflammation in interstitial cystitis
por: Shahid, Muhammad, et al.
Publicado: (2018)